⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Wave Life Sciences Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Wave Life Sciences Ltd.
↗Lexington, Massachusetts, USA
Wave Life Sciences is a clinical-stage biotechnology company focused on developing RNA medicines, specifically oligonucleotides, to treat genetic diseases. The company utilizes its proprietary PRISM platform to design, optimize, and manufacture stereopure nucleic acid therapies that can selectively target and modulate disease-causing genes.
The company's pipeline includes programs targeting rare genetic disorders, neuromuscular diseases, and metabolic conditions, such as Alpha-1 antitrypsin deficiency (AATD), Duchenne muscular dystrophy (DMD), and obesity. Wave Life Sciences operates globally with headquarters in the United States (Lexington, Massachusetts) and incorporation in Singapore.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$40M-$80M
Founded:2012
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$84M
Investors:RA Capital Management, SNBL
STOCK
Exchange:NASDAQ
Ticker:WVE
Market Cap:$1.2B
PIPELINE
Stage:Clinical
Lead Drug Stage:Phase 2
Modalities:RNA editing, Antisense silencing, RNA interference, Exon skipping
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Wave Life Sciences USA, Inc.
Key Partnerships:GSK (AATD program collaboration)
COMPETITION
Position:Emerging
Competitors:Dyne Therapeutics, Caribou Biosciences, Intellia Therapeutics, CRISPR Therapeutics, Alnylam Pharmaceuticals
LEADERSHIP
Key Executives:
Paul B. Bolno - CEO
Scientific Founders:Gregory L. Verdine, Takeshi Wada
LINKS
Website:wavelifesci.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Wave Life Sciences Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.